Beskrivning
Om boken
The third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products.Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. The third edition incorporates the latest developments and updates in the pharmaceutical community, provides more comprehensive coverage of topics, and includes more materials and case studies suited to college and university use. Biotechnology is a dynamic field with changes across R&D, clinical trials, manufacturing and regulatory processes, and the third edition of the text provides timely updates for those in this rapidly growing field.
Åtkomstkoder och digitalt tilläggsmaterial garanteras inte med begagnade böcker
Mer om Drugs: From Discovery to Approval (2015)
I juni 2015 släpptes boken Drugs: From Discovery to Approval skriven av Rick Ng. Det är den 1a upplagan av kursboken. Den är skriven på engelska och består av 536 sidor. Förlaget bakom boken är John Wiley & Sons som har sitt säte i Hoboken.
Köp boken Drugs: From Discovery to Approval på we och spara pengar.
Tillhör kategorierna
ÖvrigtÖvrigt
Referera till Drugs: From Discovery to Approval (Upplaga 1)
Harvard
Ng, R. (2015). Drugs: From Discovery to Approval. 1:a uppl. John Wiley & Sons.


